Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL21P1 is a designation for a pseudogene related to the functional ribosomal protein L21 gene (RPL21). Pseudogenes are segments of DNA that resemble functional genes but are typically non-functional due to mutations or lack of regulatory elements. RPL21P1 does not encode a functional protein and is not involved in cellular biological processes, disease mechanisms, or considered a druggable target[4][7]. The active gene, RPL21, encodes a component of the large 60S subunit of cytoplasmic ribosomes, with roles in ribosome structure, protein synthesis, and potentially other functions in hair follicle biology and cell proliferation[1][3][5]. However, RPL21P1 itself, as a processed pseudogene, lacks protein-coding capacity and is catalogued as such by genomic resources[4][7]. No known diseases, associated pathways, or drugs are linked to RPL21P1. All described functions, disease associations, and potential therapeutic target considerations apply to the parent gene RPL21, not its pseudogenes[1][5][7]. The presence of pseudogenes like RPL21P1 is a common genomic feature with no known clinical or therapeutic relevance in the current scientific literature[7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 1 (RPL21P1).